Effectiveness and safety of anti-BCMA chimeric antigen receptor T-cell treatment in relapsed/refractory multiple myeloma: a comprehensive review and meta-analysis of prospective clinical trials

Background: Chimeric antigen receptor T cells treatment targeting B cell maturation antigen (BCMA) is an emerging treatment option for relapsed/refractory multiple myeloma (RRMM) and has demonstrated outstanding outcomes in clinical studies. Objective: The aim of this comprehensive review and meta-a...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Dingyuan, Chen, Liming, Yan, Diqin, Dong, Wenliang, Chen, Min, Niu, Suping, Wang, Simin, Zhang, Jiaojiao, Nie, Xiaoyan, Fang, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318167/
https://www.ncbi.nlm.nih.gov/pubmed/37408760
http://dx.doi.org/10.3389/fphar.2023.1149138

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318167/
https://www.ncbi.nlm.nih.gov/pubmed/37408760
http://dx.doi.org/10.3389/fphar.2023.1149138

Ejemplares similares